Saving infected catheters: Why and how

Blood Purification

Volumn 23, Issue 1, 2005, Pages 23-28

  Allon, Michael ^a,b  

^a University of Alabama at Birmingham   (United States)

^b Division of Nephrology   (United States)

Author keywords

Antibiotic; Bacteremia; Dialysis catheter; Infection; Vascular access

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFTAZIDIME; CEPHALOSPORIN; GENTAMICIN; METICILLIN; VANCOMYCIN;

ARTICLE; BIOFILM; BLOOD CULTURE; CATHETER INFECTION; CLINICAL TRIAL; HEMODIALYSIS; HUMAN; MEDICAL RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERS, INDWELLING; DRUG THERAPY, COMBINATION; EQUIPMENT CONTAMINATION; HUMANS; PRACTICE GUIDELINES; RENAL DIALYSIS;

EID: 11444252859     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082007     Document Type: Article

References (26)

1. Stehman-Breen CO, Sherrard DJ, Gillen D, Caps M: Determinants of type and timing of initial permanent hemodialysis vascular access. Kidney Int 2000;57:639-645.
2. Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ: Vascular access use in Europe and in the United States: Results from the DOPPS. Kidney Int 2002;61:305-316.
3. Schwab SJ, Beathard GA: The hemodialysis catheter conundrum: Hate living with them, but can't live without them. Kidney Int 1999;56:1-17.
4. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB: Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997;127:275-280.
5. Swartz RD, Messana JM, Boyer CJ, Lunde NM, Weitzel WF, Hartman TL: Successful use of cuffed central venous hemodialysis catheters inserted percutaneously. J Am Soc Nephrol 1994;4:1719-1725.
6. Lund GB, Trerotola SO, Scheel PF, Savader SJ, Mitchell SE, Venbrux AC, Osterman FA: Outcome of tunneled hemodialysis catheters placed by radiologists. Radiology 1996;198:467-472.
7. Saad TF: Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999;34:1114-1124.
8. Beathard GA: Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 1999;10:1045-1049.
9. Shaffer D: Catheter-related sepsis complicating long-term, tunnelled central venous dialysis catheters: Management by guidewire exchange. Am J Kidney Dis 1995;25:593-596.
10. Robinson D, Suhocki P, Schwab SJ: Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange. Kidney Int 1998;53:1792-1794.
11. Tanriover B, Carlton D, Saddekni S, Hamrick K, Oser R, Westfall A, Allon M: Bacteremia associated with tunneled dialysis catheters: Comparison of two treatment strategies. Kidney Int 2000;57:2151-2155.
12. Passerini L, Lam K, Costerton JW, King EG: Biofilms on indwelling vascular catheters. Crit Care Med 1992;20:665-673.
13. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: A common cause of persistent infections. Science 1999;284:1318-1322.
14. Donlan RM: Biofilm formation: A clinically relevant microbiologic process. Clin Infect Dis 2001;33:1387-1392.
15. Donlan RM: Biofilms: Microbial life on surfaces. Emerg Infect Dis 2002;8:881-890.
16. Bastani B, Minton J, Islam S: Insufficient penetration of systemic vancomycin into the PermCath lumen. Nephrol Dial Transplant 2000;15:1035-1037.
17. Anthony TU, Rubin LG: Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports). Antimicrob Agents Chemother 1999;43:2074-2076.
18. Haimi-Cohen Y, Husain N, Meenan J, Karayalcin G, Lehrer M, Rubin LG: Vancomycin and certazidime bioactivities persist for at least 2 weeks in the lumen in ports: Simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique. Antimicrob Agents Chemother 2001;45:1565-1567.
19. Krishnasami Z, Carlton D, Bimbo L, Taylor ME, Balkovetz DF, Barker J, Allon M: Management of hemodialysis catheter related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 2002;61:1136-1142.
20. Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ: Antibiotic-lock technique: A new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1988;12:185-189.
21. Panagea S, Galloway A: Intravascular-catheter-related infections (letter). Lancet 1998;351:1738-1739.
22. Atkinson JB, Chamberlin K, Boody BA: A prospective randomized trial of urokinase as an adjuvant in the treatment of proven Hickman catheter sepsis. J Pediatr Surg 1998;33:714-716.
23. Boorgu R, Dubrow AJ, Levin NW, My H, Canaud BJ, Lentino JR, Wentworth DW, Hatch DA, Megerman J, Prosl FR, Gandhi VC, Ing TS: Adjunctive antibiotic/anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device. ASAIO J 2000;46:767-770.
24. Vardhan A, Davies J, Daryanani I, Crowe A, McClelland P: Treatment of haemodialysis catheter-related infections. Nephrol Dial Transplant 2002;17:1149-1150.
25. Poole CV, Carlton D, Bimbo L, Allon M: Treatment of catheter-related bacteremia with an antibiotic lock protocol: Effect of bacterial pathogen. Nephrol Dial Transplant 2004;19:1237-1244.
26. Allon M, Bailey R, Ballard R, Deierhoi MH, Hamrick K, Oser R, Rhynes VK, Robbin ML, Saddekni S, Zeigler ST: A multidisciplinary approach to hemodialysis access: Prospective evaluation. Kidney Int 1998;53:473-479.